Skip to main content
Clinical Trials/JPRN-UMIN000051823
JPRN-UMIN000051823
Recruiting
未知

Clinical studies to elucidate the molecular mechanisms associated with the pathogenesis of amyotrophic lateral sclerosis (ALS) and to identify effective drug targets - Clinical research to elucidate ALS pathogenesis and to identify drug targets

Keio University, School of Medicine0 sites600 target enrollmentAugust 7, 2023

Overview

Phase
未知
Intervention
Not specified
Conditions
Amyotrophic lateral sclerosis
Sponsor
Keio University, School of Medicine
Enrollment
600
Status
Recruiting
Last Updated
2 years ago

Overview

Brief Summary

No summary available.

Registry
who.int
Start Date
August 7, 2023
End Date
March 31, 2032
Last Updated
2 years ago
Study Type
Observational
Sex
All

Investigators

Eligibility Criteria

Inclusion Criteria

  • Not provided

Exclusion Criteria

  • The case when the subject does not agree to participate in this study.

Outcomes

Primary Outcomes

Not specified

Similar Trials